5 months ago
SNDX
AnalystsJustin ZelinJustin Zelin's Stock Forecasts
AnalystsJustin Zelin
Sectors:
Industries:
Analyst Ranking
Top 40%
#2033 out of 5164 analysts
Average Return
+0.98%
Win Rate
28%15 out of 54
Risk vs Reward
Poor
Good
Justin Zelin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +437.68% | $3.45 | $18.55 | 2022-06-29 - 2023-06-28 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-29 - 2024-03-28 | Strong Buy |
Bellus Health IncBLU | +241.96% | $2.86 | $9.78 | 2021-07-29 - 2022-07-28 | Strong Buy |
Viking Therapeutics IncVKTX | +216.53% | $24.65 | $78.01 | 2023-05-16 - 2024-05-15 | Strong Buy |
Casi Pharmaceuticals IncCASI | +130.16% | $1.89 | $4.35 | 2022-11-16 - 2023-11-15 | Strong Buy |
Justin Zelin Analyst Color
Get additional color on Justin Zelin's coverage of popular stocks
a year ago
IDYA
2 years ago
VKTX
2 years ago
VKTX
2 years ago
IMCR
2 years ago
ETNB
3 years ago
SNDX
3 years ago
MBIO
3 years ago
LEGN
3 years ago
GRCL
3 years ago
LEGN
3 years ago
VKTX
Justin Zelin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $45.00 | +123.66% | Initiates Coverage On | 22 days ago |
Syndax Pharmaceuticals IncSNDX | 5 | Strong Buy | $56.00 | +166.54% | Reiterates | 23 days ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $50.00 | +90.55% | Initiates Coverage On | 2 months ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $8.00 | +357.14% | Reiterates | 2 months ago |
Novabridge BiosciencesNBP | 4 | Strong Buy | $9.00 | +126.13% | Reiterates | 2 months ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $62.00 | +79.35% | Reiterates | 2 months ago |
Canaan IncCAN | 1 | Strong Buy | $8.00 | +1,059.42% | Reiterates | 3 months ago |
Viking Therapeutics IncVKTX | 5 | Strong Buy | $125.00 | +255.32% | Reiterates | 3 months ago |
Jasper Therapeutics IncJSPR | 3 | Strong Buy | $7.00 | +282.51% | Maintains | 3 months ago |
Verastem IncVSTM | 2 | Strong Buy | $20.00 | +159.07% | Reiterates | 4 months ago |
Immunitybio IncIBRX | 1 | Strong Buy | $6.00 | +203.03% | Initiates Coverage On | a year ago |
Enliven Therapeutics IncELVN | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | a year ago |
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Carisma Therapeutics IncCARM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Lyra Therapeutics IncLYRA | 1 | Strong Buy | $750.00 | N/A | Assumes | 2 years ago |
Mustang Bio IncMBIO | 4 | Strong Buy | $800.00 | N/A | Maintains | 2 years ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $91.00 | N/A | Maintains | 2 years ago |
Adicet Bio IncACET | 2 | Strong Buy | $160.00 | N/A | Maintains | 2 years ago |
Prokidney CorpPROK | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
89bio IncETNB | 2 | Strong Buy | $37.00 | N/A | Maintains | 2 years ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $90.00 | N/A | Maintains | 3 years ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $20.00 | N/A | Maintains | 3 years ago |
Kura Oncology IncKURA | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | 3 years ago |
Novo Nordisk A SNVO | 1 | Strong Buy | $15.50 | N/A | Maintains | 3 years ago |
Lite Strategy IncLITS | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Casi Pharmaceuticals IncCASI | 2 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Bellus Health IncBLU | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 4 years ago |
Surface Oncology IncSURF | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 5 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.